Annual Working Capital
$451.75 M
-$170.94 M-27.45%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual working capital is $451.75 million, with the most recent change of -$170.94 million (-27.45%) on December 31, 2023.
- During the last 3 years, RARE annual working capital has fallen by -$653.95 million (-59.14%).
- RARE annual working capital is now -59.14% below its all-time high of $1.11 billion, reached on December 31, 2020.
Performance
RARE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$514.60 M
-$177.17 M-25.61%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly working capital is $514.60 million, with the most recent change of -$177.17 million (-25.61%) on September 30, 2024.
- Over the past year, RARE quarterly working capital has increased by +$169.39 million (+49.07%).
- RARE quarterly working capital is now -53.46% below its all-time high of $1.11 billion, reached on December 31, 2020.
Performance
RARE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RARE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.4% | +49.1% |
| 3 y3 years | -59.1% | -27.6% |
| 5 y5 years | +0.9% | -1.6% |
RARE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.1% | at low | -34.5% | +49.1% |
| 5 y | 5-year | -59.1% | at low | -53.5% | +49.1% |
| alltime | all time | -59.1% | +4438.4% | -53.5% | +943.7% |
Ultragenyx Pharmaceutical Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $514.60 M(-25.6%) |
| Jun 2024 | - | $691.77 M(+97.4%) |
| Mar 2024 | - | $350.39 M(-22.4%) |
| Dec 2023 | $451.75 M(-27.5%) | $451.75 M(+30.9%) |
| Sep 2023 | - | $345.21 M(-24.6%) |
| Jun 2023 | - | $457.76 M(-16.5%) |
| Mar 2023 | - | $548.16 M(-12.0%) |
| Dec 2022 | $622.69 M(-7.8%) | $622.69 M(-20.7%) |
| Sep 2022 | - | $785.31 M(+71.5%) |
| Jun 2022 | - | $457.91 M(-15.2%) |
| Mar 2022 | - | $540.29 M(-20.0%) |
| Dec 2021 | $675.24 M(-38.9%) | $675.24 M(-5.0%) |
| Sep 2021 | - | $710.95 M(-13.6%) |
| Jun 2021 | - | $822.42 M(-12.9%) |
| Mar 2021 | - | $943.89 M(-14.6%) |
| Dec 2020 | $1.11 B(+47.9%) | $1.11 B(+64.8%) |
| Sep 2020 | - | $670.82 M(-2.3%) |
| Jun 2020 | - | $686.31 M(-1.6%) |
| Mar 2020 | - | $697.46 M(-6.7%) |
| Dec 2019 | $747.72 M(+67.0%) | $747.72 M(+42.9%) |
| Sep 2019 | - | $523.18 M(-16.2%) |
| Jun 2019 | - | $624.42 M(-13.3%) |
| Mar 2019 | - | $720.01 M(+60.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $447.64 M(+125.4%) | $447.64 M(-10.6%) |
| Sep 2018 | - | $500.80 M(-7.0%) |
| Jun 2018 | - | $538.69 M(+2.8%) |
| Mar 2018 | - | $524.00 M(+163.9%) |
| Dec 2017 | $198.57 M(-41.8%) | $198.57 M(-39.2%) |
| Sep 2017 | - | $326.64 M(-8.5%) |
| Jun 2017 | - | $357.12 M(-9.1%) |
| Mar 2017 | - | $392.93 M(+15.1%) |
| Dec 2016 | $341.44 M(-19.1%) | $341.44 M(-6.8%) |
| Sep 2016 | - | $366.35 M(-3.4%) |
| Jun 2016 | - | $379.10 M(-5.3%) |
| Mar 2016 | - | $400.35 M(-5.2%) |
| Dec 2015 | $422.29 M(+133.4%) | $422.29 M(-3.1%) |
| Sep 2015 | - | $435.97 M(+39.1%) |
| Jun 2015 | - | $313.49 M(-6.8%) |
| Mar 2015 | - | $336.27 M(+85.9%) |
| Dec 2014 | $180.90 M(+266.9%) | $180.90 M(-7.5%) |
| Sep 2014 | - | $195.67 M(+31.1%) |
| Jun 2014 | - | $149.27 M(-8.3%) |
| Mar 2014 | - | $162.82 M(+230.2%) |
| Dec 2013 | $49.30 M(-40.8%) | $49.30 M(-19.3%) |
| Sep 2013 | - | $61.07 M(-26.7%) |
| Dec 2012 | $83.26 M(+736.4%) | $83.26 M |
| Dec 2011 | $9.95 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual working capital?
- What is the all time high annual working capital for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual working capital year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly working capital?
- What is the all time high quarterly working capital for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly working capital year-on-year change?
What is Ultragenyx Pharmaceutical annual working capital?
The current annual working capital of RARE is $451.75 M
What is the all time high annual working capital for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual working capital is $1.11 B
What is Ultragenyx Pharmaceutical annual working capital year-on-year change?
Over the past year, RARE annual working capital has changed by -$170.94 M (-27.45%)
What is Ultragenyx Pharmaceutical quarterly working capital?
The current quarterly working capital of RARE is $514.60 M
What is the all time high quarterly working capital for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly working capital is $1.11 B
What is Ultragenyx Pharmaceutical quarterly working capital year-on-year change?
Over the past year, RARE quarterly working capital has changed by +$169.39 M (+49.07%)